-
PRE-FORMULATION
DEVELOPMENTWe understand poor pre-formulation studies may lead to delays in pre-clinical and clinical development programs. With our world-leading expertise in development of methods for inhaled drug product characterisation, we can provide the solid foundation required for successful transition of early phase development programs through to clinical.
-
FORMULATION
DEVELOPMENTOrally inhaled and nasal drug products are complex systems that are highly dependent on interactions between device and formulation components. Our INTERHALE technologies offer a range of tailored and robust formulation development solutions for all types of pMDIs and DPI device platforms.
-
ANALYTICAL
CHARACTERISATIONNanopharm was founded on its advanced analytical characterisation services and its understanding of how input material physico-chemical and mechanical properties affect product specification, functionality and stability of orally inhaled and nasal drug products.